||Former White House Deputy Drug Czar Andrea G. Barthwell, M.D. Joins AZZLY¬Æ as Senior Advisor and Strategist
||Former White House Deputy Drug Czar Andrea G. Barthwell, M.D. Joins AZZLY¬Æ as Senior Advisor and Strategist Share Article Former Deputy Director for Demand Reduction in the White House Office of National Drug Control Policy (ONDCP), the Honorable Andrea Barthwell, M.D., DFASAM, has joined AZZLY¬Æ, Inc., as Senior Advisor and Strategist. Dr. Barthwell brings with her decades of experience in and dedication to the field of addiction medicine ...
||Meeting the rising demand for medical device consumable manufacturing
||... it has become feasible to incorporate electronics into complex consumables that maintain the healthcare industry’s traceability and safety requirements. From in-vitro diagnostic (IVD) platforms and blood glucose monitoring tools to ambulatory systems and clinical wearables , more and more of these medical devices require high-volume, complex consumables to make patient care more effective. Whether or not this design approach is an example of a “razor and blades” business model ...
||Smith+Nephew announces new milestone with its OXINIUM™ Advanced Bearing System implants surpassing two million procedures
||LONDON Smith+Nephew (LSE:SN,NYSE: SNN ), the global medical technology business, today announced that over two million patients have been treated with implants made from OXINIUM Technology - a proprietary oxidized zirconium alloy used in hip and knee replacements. Smith+Nephew's OXINIUM Technology OXINIUM is a unique material that combines the strength of metal with the wear resistance of ceramic. Its hardness, low-friction and resistance to roughening and abrasion ...
||Biofourmis acquires Biovotion, inks commercialization deal with Novartis - plugilo.blog
||... and equity. The acquisition will include Biovotion’s clinical grade-wearable technology Everion, as well as its entire portfolio and pipeline, team, clients, partners and patents. According to Biofourmis, the patents include both consumer and clinical wearables . The plan is to combine Biovotion’s wearables with Biofourmis’ analytics platform. The acquisition news coincided with the announcement that Biofourmis is teaming up with pharma giant Novartis for the commercial rollout of a platform ...
||Business of Health Care Clinical Wearables
||As wearable smart technology makers push more deeply into healthcare, their creations are crossing the line into becoming medical devices. Links to article: Business of Health Care Clinical Wearables ...
||Global Medical Technologies Industry Predictions 2019-2024 - ResearchAndMarkets.com
||DUBLIN- The "Global Medical Technologies Industry Predictions, 2019" report has been added to ResearchAndMarkets.com's offering. The report estimates that the 4 themes would result in a huge set of new and unprecedented growth opportunities for existing medtech participants. The study highlights a set of 20 such growth opportunities cutting across these themes, with a combined incremental value of $64.10 billion, over and above the $413.90 billion traditional market size, in ...
||Amazon Web Services updated its recognition tech — here's what you need to know (AMZN)
||DIGITAL HEALTH BRIEFING: Amazon to sell medical devices, supplies — FDA approves device to help opioid addicts — Clinical wearables usage takes off This story was delivered to BI Intelligence Apps and Platforms Briefing subscribers. To learn more and subscribe, please click here . Amazon Web Services (AWS) announced three major updates to its Rekognition service, which makes it easy to add deep learning computer vision analysis and capabilities to the cloud. The ...
||DIGITAL HEALTH BRIEFING: Amazon to sell medical devices, supplies — FDA approves device to help opioid addicts — Clinical wearables usage takes off
||Sign up and receive Digital Health Briefing free to your inbox. Have feedback? We'd like to hear from you. Write me at: . AMAZON COULD SOON BEGIN SHIPPING MEDICAL DEVICES, SUPPLIES: Over the past year, Amazon obtained several wholesale pharmacy licenses in a number of US states, leading to speculation that the company may enter the pharmaceutical market. However, earlier this week, correspondence between the company and regulators in Tennessee and ...